NO910935D0 - Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.Info
- Publication number
- NO910935D0 NO910935D0 NO910935A NO910935A NO910935D0 NO 910935 D0 NO910935 D0 NO 910935D0 NO 910935 A NO910935 A NO 910935A NO 910935 A NO910935 A NO 910935A NO 910935 D0 NO910935 D0 NO 910935D0
- Authority
- NO
- Norway
- Prior art keywords
- bonded
- procedure
- preparation
- pyrazole derivatives
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/175—Saturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909005354A GB9005354D0 (en) | 1990-03-09 | 1990-03-09 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO910935D0 true NO910935D0 (no) | 1991-03-08 |
| NO910935L NO910935L (no) | 1991-09-10 |
Family
ID=10672340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91910935A NO910935L (no) | 1990-03-09 | 1991-03-08 | Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5389659A (no) |
| EP (1) | EP0446062A1 (no) |
| JP (1) | JPH0625175A (no) |
| KR (1) | KR920005717A (no) |
| AU (1) | AU636720B2 (no) |
| CA (1) | CA2037872A1 (no) |
| FI (1) | FI911161A (no) |
| GB (1) | GB9005354D0 (no) |
| IE (1) | IE910783A1 (no) |
| IL (1) | IL97481A0 (no) |
| NO (1) | NO910935L (no) |
| NZ (2) | NZ244221A (no) |
| PT (1) | PT96976A (no) |
| TW (1) | TW211004B (no) |
| ZA (1) | ZA911721B (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2659655B1 (fr) * | 1990-03-19 | 1992-07-24 | Union Pharma Scient Appl | Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| WO1991015479A1 (en) * | 1990-03-30 | 1991-10-17 | Merck & Co., Inc. | Substituted pyrazoles, isoxazoles and isothiazoles |
| GB9110623D0 (en) * | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| AP254A (en) * | 1991-09-05 | 1993-05-05 | Glaxo Group Ltd | C-Linked pyrazole derivatives. |
| WO1993005025A1 (en) * | 1991-09-06 | 1993-03-18 | Glaxo Group Limited | C-linked pyrazole derivatives |
| GB2263638A (en) * | 1992-01-28 | 1993-08-04 | Merck & Co Inc | Substituted pyrazoles, isoxazoles and isothiazoles as neurotensin antagonists |
| US5312958A (en) * | 1992-01-31 | 1994-05-17 | Takeda Chemical Industries, Ltd. | Process for producing 4-bromomethylbiphenyl compounds |
| EP0577025A3 (de) * | 1992-07-01 | 1998-02-04 | Hoechst Aktiengesellschaft | Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen |
| DE69330593T2 (de) * | 1992-12-22 | 2002-06-27 | Takeda Chemical Industries, Ltd. | Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung |
| JPH072859A (ja) * | 1993-01-28 | 1995-01-06 | Upjohn Co:The | ピラゾール誘導体およびこれを有効成分とする医薬組成物 |
| US5262412A (en) * | 1993-03-10 | 1993-11-16 | Merck & Co., Inc. | Substituted pyrazoles, compositions and use |
| ES2105939B1 (es) * | 1994-08-02 | 1998-07-01 | Uriach & Cia Sa J | Nuevos pirazoles con actividad antagonista de la angiotensina ii. |
| TW418204B (en) * | 1997-03-28 | 2001-01-11 | Dev Center Biotechnology | Novel 1,2,4-triazine-5-ketonyl benzene derivatives and the analogs, the preparation, and the pharmaceutical compositions as angiotension II receptor antogonists |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| GB0402262D0 (en) * | 2004-02-02 | 2004-03-10 | Novartis Ag | Process for the manufacture of organic compounds |
| US7411082B2 (en) | 2004-03-29 | 2008-08-12 | Cambridge University Technical Services Ltd. | Synthesizing method for compound, and catalyst for synthesis reaction |
| WO2005105719A1 (ja) | 2004-04-28 | 2005-11-10 | Cambridge University Technical Services Limited | 化合物の合成方法および合成反応触媒 |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2014136781A1 (ja) * | 2013-03-04 | 2014-09-12 | 国立大学法人 東京大学 | 蛍光プローブ |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EA201592263A1 (ru) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
-
1990
- 1990-03-09 GB GB909005354A patent/GB9005354D0/en active Pending
-
1991
- 1991-03-08 FI FI911161A patent/FI911161A/fi not_active Application Discontinuation
- 1991-03-08 JP JP3069159A patent/JPH0625175A/ja active Pending
- 1991-03-08 IL IL97481A patent/IL97481A0/xx unknown
- 1991-03-08 NZ NZ244221A patent/NZ244221A/en unknown
- 1991-03-08 US US07/666,746 patent/US5389659A/en not_active Expired - Fee Related
- 1991-03-08 AU AU72736/91A patent/AU636720B2/en not_active Ceased
- 1991-03-08 KR KR1019910003745A patent/KR920005717A/ko not_active Application Discontinuation
- 1991-03-08 CA CA002037872A patent/CA2037872A1/en not_active Abandoned
- 1991-03-08 EP EP91301933A patent/EP0446062A1/en not_active Withdrawn
- 1991-03-08 ZA ZA911721A patent/ZA911721B/xx unknown
- 1991-03-08 IE IE078391A patent/IE910783A1/en unknown
- 1991-03-08 NZ NZ237366A patent/NZ237366A/en unknown
- 1991-03-08 NO NO91910935A patent/NO910935L/no unknown
- 1991-03-08 PT PT96976A patent/PT96976A/pt not_active Application Discontinuation
- 1991-03-12 TW TW080101944A patent/TW211004B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ237366A (en) | 1992-11-25 |
| TW211004B (no) | 1993-08-11 |
| KR920005717A (ko) | 1992-04-03 |
| EP0446062A1 (en) | 1991-09-11 |
| CA2037872A1 (en) | 1991-09-10 |
| IE910783A1 (en) | 1991-09-11 |
| NO910935L (no) | 1991-09-10 |
| FI911161A (fi) | 1991-09-10 |
| US5389659A (en) | 1995-02-14 |
| GB9005354D0 (en) | 1990-05-02 |
| ZA911721B (en) | 1992-02-26 |
| AU7273691A (en) | 1991-09-12 |
| NZ244221A (en) | 1992-11-25 |
| JPH0625175A (ja) | 1994-02-01 |
| FI911161A0 (fi) | 1991-03-08 |
| AU636720B2 (en) | 1993-05-06 |
| IL97481A0 (en) | 1992-06-21 |
| PT96976A (pt) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO910935L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater. | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
| NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO912672L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer. | |
| NO895086D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. | |
| NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO903088D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| NO910395L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater. | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO910874D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
| NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO900919L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske etere. | |
| NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO913187L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. | |
| NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
| NO904470D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater. | |
| NO891045L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater. | |
| NO900812L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive laktamderivater. | |
| NO891677D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater. | |
| NO890506L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater. |